Literature DB >> 856672

Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.

R Ebert, R Arnold, W Creutzfeldt.   

Abstract

The effect of intravenous glucagon infusion on serum levels of immunoreactive GIP (IR-GIP), insulin (IRI), gastrin (IRG), and on blood glucose has been investigated in six healthy volunteers in the fasting state and during ingestion of a mixed standard meal. Glucagon (500 ng/kg/min) lowered significantly serum levels of IR-GIP and IRG below the fasting values and increased the levels of IRI and blood glucose. Glucagon (50 ng/kg/min) infused 30 minutes before and continued 90 minutes after ingestion of a test meal abolished the IR-GIP response, suppressed significantly the IRG response, and left the IRI response unchanged. The same glucagon dose infused 60 minutes after ingestion of the test meal decreased significantly the raised levels of IR-GIP and IRG to fasting levels without changing IRI values. It is concluded that exogenous glucagon inhibits Gip release at the level of the GIP-producing cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856672      PMCID: PMC1411287          DOI: 10.1136/gut.18.2.121

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  PROMOTION OF INSULIN SECRETION BY GLUCAGON.

Authors:  E SAMOLS; G MARRI; V MARKS
Journal:  Lancet       Date:  1965-08-28       Impact factor: 79.321

2.  [Influence of glucagon on jejunal absorption of glucose, water and electrolytes in man (author's transl)].

Authors:  H Gottesbüren; H Leising; H Menge; H Lorenz-Meyer; E O Riecken
Journal:  Klin Wochenschr       Date:  1974-10-01

3.  Glucagon control of fasting glucose in man.

Authors:  F P Alford; S R Bloom; J D Nabarro; R Hall; G M Besser; D H Coy; A J Kastin; A V Schally
Journal:  Lancet       Date:  1974-10-26       Impact factor: 79.321

4.  Influence of glucagon on the human jejunum.

Authors:  T Hicks; L A Turnberg
Journal:  Gastroenterology       Date:  1974-12       Impact factor: 22.682

5.  Influence of feeding and sham feeding upon serum gastrin and gastric acid secretion in control subjects and duodenal ulcer patients.

Authors:  G Mayer; R Arnold; G Feurle; K Fuchs; H Ketterer; N S Track; W Creutzfeldt
Journal:  Scand J Gastroenterol       Date:  1974-11       Impact factor: 2.423

6.  [On radio-immunologic determination of insulin in blood].

Authors:  F Melani; H Ditschuneit; K M Bartelt; H Friedrich; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1965-09-15

7.  Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis--relationship to endocrine and exocrine insufficiency.

Authors:  R Ebert; W Creutzfeldt; J C Brown; H Frerichs; R Arnold
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

8.  Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.

Authors:  J E Gerich; M Lorenzi; D M Bier; E Tsalikian; V Schneider; J H Karam; P H Forsham
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

9.  Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome).

Authors:  W Creutzfeldt; R Arnold; C Creutzfeldt; N S Track
Journal:  Hum Pathol       Date:  1975-01       Impact factor: 3.466

10.  Effects of glucagon, dibutyryl cyclic 3',5'-adenosine monophosphate, and theophylline on calcitonin secretion in vitro.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1970-07       Impact factor: 14.808

View more
  3 in total

1.  Adrenergic modulation of gastric inhibitory polypeptide secretion in man.

Authors:  M Salera; R Ebert; P Giacomoni; L Pironi; S Venturi; R Corinaldesi; M Miglioli; L Barbara
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

2.  Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.

Authors:  D K Andersen; D Elahi; J C Brown; J D Tobin; R Andres
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

3.  Endocrine pancreatic control of the release of gastric inhibitory polypeptide. A possible physiological role for C-peptide.

Authors:  J R Dryburgh; S M Hampton; V Marks
Journal:  Diabetologia       Date:  1980-10       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.